Abstract

Quantum dots (QDs) are powerful materials in various bioapplications based on their excellent optical and electronic properties. For the application of various fields of QDs, surface modification of QDs is necessary. However, surface modification in QDs may result in a reduction in quantum yield (QY). This reduction of QY causes many weaknesses in the biological application of QDs. In this study, CdSeZnS/ZnS alloy QDs were used to prepare antibody-conjugated QDs for a sandwich immunoassay. The alloy QDs displayed a QY of 84.5% that was maintained at 83.0% (98.2% of QY was maintained) after surface modification with the anti-rabbit IgG as a model study. Surface-modified QDs successfully detected their corresponding target through antibody-antigen binding. The limit of detection was  ng mL-1 for rabbit IgG.

1. Introduction

Semiconductor quantum dots (QDs) are increasingly being used in both fundamental and applied research because of their optical and electronic properties [13]. QDs can absorb a broad range of light and emit the specific wavelength of light which depends on their size. With this property, one of the useful applications of QDs is fluorescent probes in biological imaging [4]. While traditional fluorescent probes have disadvantages such as easy photodegradation, low fluorescence, and photobleaching [5], QDs have excellent optical characteristics and chemical stability including higher photostability, wide band-edge absorption, narrow emission, and high quantum yield (QY) [6]. However, QDs also have limitations for bioapplication. Typically, QDs are dispersed only in nonpolar solvents and limited with severe intermittency in emission. Furthermore, their nonspecific binding can lead to misinterpretation of experimental results. The critical issue of QDs is toxicity which can cause acute or chronic diseases. Another issue of QDs is their instability in biological media because of their high hydrophobic property. Thus, surface modification is required to make QDs which have hydrophilic characteristic and more stable in a biological environment [714].

Many studies have been sought to overcome these limitations of QDs. The hydrophobic surface of QDs was changed as a hydrophilic surface via encapsulation with a silica shell, and these silica encapsulated QDs were more suitable for biomedical applications compared to bare QDs [7, 1519]. Amphiphilic polymer-covered QDs displayed improved stability over a wide pH range and were less prone to nonspecific binding [20, 21]. Studies which aimed at enhancing the safety of QDs described that a thick shell of ZnS could reduce QDs’ toxicity to cells and increase photoluminescence. Moreover, the thick shell of ZnS makes the fluorescence quantum yield more stable and decrease the blinking, and it extends the absorption and emission spectrum [2, 2226].

Enzyme-linked immunosorbent assay (ELISA) is a biochemical method for detecting or measuring a molecule, mostly a protein. It is based on the antigen-antibody reaction which has been applied in various different fields such as diagnosis, toxicology, food industry, pharmaceutical industry, immunology, and vaccine development [27]. ELISA possesses advantages that include high sensitivity, specificity, and fast reaction, but it also has many disadvantages such as size limitations, disposal of sensitivity to temperature, and easy decay. To overcome these weaknesses, enormous innovations such as ultrasensitive enzymes and better antibodies have been developed. As good fluorescence probes, QDs were utilized for signal enhancement [2832].

In many studies, CdSe/ZnS core/shell QDs were fabricated and applied in biological detection [3342]. Li’s group synthesized CdSe/ZnS QDs and proceeded an assay for the detection of C-reactive protein (CRP). The test for CRP detection in the above study had good detection results, but the QY of QDs was 63% in hydrophobic modification and the QY showed an 8% reduction after hydrophilic modification [43]. For another study, the protein was introduced on CdSe/ZnS QDs. The particle that conjugated with antibody was identified with luminescence images on various proteins and compared the efficiency of each particle. It was a good result in biological application. However, in the case of QY of CdSe/ZnS QDs used in the above paper, it was 35-50% before the ligand exchange, and the QY after ligand exchange was not checked correctly [44]. In general, QDs showed a sharp decrease in QY after ligand exchange, so maintaining QY which is not dropped significantly after surface modification is needed [4547].

In this study, we fabricated a cadmium selenide zinc sulfide/zinc sulfide (CdSeZnS/ZnS) alloy QDs that displayed a high QY which was 84.5%; after surface modification, QY was 83.0% (98.2% of QY was maintained). The surface of alloy QDs was modified via conjugation with antibody molecules, and commercial QDs were used as a control. The conjugation of the commercial QDs markedly reduced QY. By contrast, alloy QDs retained a high QY after surface modification and then were successful in sensitive detecting rabbit IgG. The results indicated that alloy QDs have better stability in QY and better capability in bioconjugation than commercial QDs.

2. Materials and Methods

2.1. Chemical and Materials

All reagents were used as received from the suppliers without further purification. Cadmium oxide (CdO, 99.9%) was purchased from Alfa Aesar (Ward Hill, MA, USA). Tri-n-octylphosphine (TOP, 97%) was purchased from STREM Chemicals (Newburyport, MA, USA). Selenium (Se, 99.5%) was purchased from Acros Organics (Geel, Belgium). Sulfur (S, 99%) and ammonium hydroxide (NH4OH, 27%) were purchased from Daejung (Siheung, Korea). Zinc acetate (Zn(Ac)2, 99.99%), 3-mercaptopropionic acid (MPA), oleic acid (OA, 90%), 1-octadecene (ODE, 90%), 1-octanethiol (98.5%), acetone (99.9%), chloroform (CHCl3, 99.5%), 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC), sulfo-N-hydroxysulfosuccinimide (sulfo-NHS), phosphate-buffered saline (PBS, pH 7.4), TWEEN® 20, bovine serum albumin (BSA), and commercial QDs (CdSeS/ZnS-alloyed quantum dot) [48] were purchased from Sigma-Aldrich (St. Louis, MO, USA). NH2-PEG-COOH (MW 600) was purchased from NANOCS. Rabbit immunoglobulin G (IgG) and anti-rabbit IgG antibody were purchased from Bore Da Biotech Co. (Seongnam, Korea). QE-2000 (Otsuka Electronics Co., Ltd.) was used to measure the QY of alloy QDs.

2.2. Preparation of Alloy QDs

Hydrophobic QDs were prepared by mixing 75 mL of ODE and 15 mL of OA and adding 1.1 g Zn(Ac)2 and 0.384 g of CdO in a three-necked flask, and the mixture was incubated under a vacuum at 150°C for 1 h. After 1 h, moisture in the flask was removed and the flask was heated to 300°C in the presence of nitrogen gas, with the addition of 0.6 mL of TOP and 0.048 g of Se for 3 min. This was followed by the addition of 0.5 mL of 1-dodecanethiol and reaction for 20 min. Three milliliters of TOP and 0.192 g of sulfur were added to the flask and reacted for 10 min, followed by 1 mL of 1-dodecanethiol and reacted for another 10 min. The flask was then cooled to room temperature. The QDs were washed in acetone and dispersed in CHCl3. The hydrophobic alloy QDs were prepared by mixing 60 mL of ODE and 10 mL of OA, with the addition of 1.1 g Zn(Ac)2 and 0.384 g of CdO in a three-necked flask under a vacuum at 150°C for 1 h. Moisture was removed, the flask was heated to 300°C in the presence of nitrogen gas, the prepared hydrophobic QDs were added, and the reaction was allowed to proceed for 10 min. Three milliliters of TOP and 0.192 g of S were added and reacted for 10 min, and the flask was cooled to room temperature. The alloy QDs were washed in acetone and dispersed in CHCl3.

2.3. Characterization of QDs

The photoluminescence quantum efficiency of heat-treated specimens excited at 390 nm was measured using a quantum efficiency measurement system (QE-2000, Otsuka Electronics Co., Ltd.). While measuring the quantum efficiency, the emission and excitation sources were also collected by the integrated spheres.

2.4. Ligand Exchange of QDs

Ligands of alloy QD and commercial QD were exchanged using the carboxyl group-contained ligands as per a previous description for modification. First, the reaction solution containing 1.0 mL of MPA, 1 mL of NH4OH, and 30 mL of CHCl3 was prepared in a Falcon tube, which was mixed by rotation for 2 h. Then, 10 mg of each QD, 10 mL of distilled water, and 10 mL of reaction buffer were mixed in a Falcon tube and allowed to react by rotation for 2 h. The supernatant was collected and was washed several times with CHCl3. After alloy QD ligands were exchanged with the carboxyl group, they were washed with acetone and then passed through an Amicon filter-sized 100,000 MWCO and dispersed in distilled water.

2.5. Preparation of Anti-Rabbit IgG-Conjugated QDs

The carboxyl group-functionalized commercial QDs or alloy QDs (1.0 mg mL-1 in deionized water) were incubated with sulfo-NHS (2 mg), EDC (2 mg), and PBS buffer for 30 min at 25°C to activate the carboxyl groups. The reaction mixture was washed several times with PBS buffer and centrifuged at 13,000 rpm for 10 min at 4°C. Then, it was incubated with NH2-PEG-COOH (10 μL) for 2 h at 25°C, and unreacted carboxyl groups were blocked with ethanolamine (3.2 μL) for 30 min at 25°C. After repeating the process of leading to sulfo-NHS, EDC, NH2-PEG-COOH, and ethanolamine once again to prevent steric hindrance that occurred immunoassay experiment, the QDs were reacted with anti-rabbit IgG (15 μg) for 1 h at 25°C. The reaction mixture was washed several times with PBS and centrifuged at 13,000 rpm for 10 min at 4°C. The sulfo-NHS-activated QDs were reacted with anti-rabbit IgG (15 μg) for 1 h at 25°C. The reaction mixture was washed with PBS containing 0.1 wt.% TWEEN® 20 and centrifuged at 13,000 rpm for 10 min at 4°C, and antibody-conjugated QDs were redispersed in PBS containing 5.0 wt.% BSA for 2 h at 25°C to prevent nonspecific binding. The solution was washed several times with PBS containing 0.1 wt.% TWEEN® 20, centrifuged at 13,000 rpm for 10 min at 4°C, and redispersed in PBS.

2.6. QD-Based Sandwich Immunoassay for Detection of Rabbit IgG

The assay was performed in 96-well immune plates (SPL Life Science Co., Ltd, Seoul, Korea). First,  ng mL-1 of antibody in PBS, as the capture antibody of IgG (target), was added to the wells. After incubation for 1 h with shaking the plate at 25°C, the plate was stored overnight at 4°C. To remove the unbound antibody, each microwell was washed three times with PBS (300 μL well-1). This step was followed by adding 0.5 wt.% BSA solution to the microwells (300 μL well-1) and incubating for 2 h at 25°C. Then, the BSA solution was removed and wells were washed three times using PBS containing 0.1 wt.% TWEEN® 20 (300 μL well-1). Next, 100 μL of target (rabbit IgG) solution with corresponding concentrations was added to the microwells. The microplate was incubated for 2 h at 37°C, followed by three washes with PBS containing 0.1 wt.% TWEEN® 20 (300 μL well-1). IgG antibody-conjugated QDs ( ng mL-1) were added to each microwell and incubated for 2 h at 37°C. Then, we washed the microwell three times using PBS containing 0.1 wt.% TWEEN® 20 (300 μL well-1) and 300 μL of PBS was added into each microwell. After the immunoassay experiment, fluorescence intensity was measured (excitation wavelength filter was used to 385 nm; emission wavelength filter was used to 630 nm).

3. Results and Discussion

3.1. Synthesis and Characterization of Anti-Rabbit IgG Antibody-Conjugated QDs

Our new alloy QDs was established via three strategies to improve the final stability of particles. First, the method of depositing a secondary shell after the primary refining core was used in the core synthesis method of the alloy QDs. Second, the ligand of the primary shell in the synthetic method was applied with a mixture of various thiol-contained ligands (1-octanethiol, 1-dodecanethiol, 1-decanrthiol...) which reduced the lattice mismatch in the next response to increase the stability of the core in the alloy QDs. Third, in the synthetic method, the precursor of the shell was added sequentially to enhance particle stability.

Figure 1(a) shows a representative transmission electron microscopy image of bare QDs, and Figure 1(b) shows QD size distribution, respectively. The average size of commercial QDs was  nm, and its relative standard deviation was 0.16. The average size of alloy QDs was  nm, and its relative standard deviation was 0.21. They were also sized through DLS with water as a solvent (Figures S1 and S2).

The surfaces of QDs were functionalized with MPA to produce a hydrophilic surface with carboxyl groups. To conjugate an antibody, the carboxyl groups were activated using EDC and sulfo-NHS. To evaluate the quality of two kinds of antibody-conjugated QDs, ultraviolet-visible (UV-Vis) absorbance, fluorescence intensity, zeta potential, and QY examination were performed at the same concentrations. The UV-Vis absorbance at 300-400 nm was higher in alloy QDs than in commercial QDs (Figure 2(a)). Fluorescence intensity was measured at an emission and excitation wavelength of 385 nm and 600–650 nm in 0.05 mg mL-1 of QD concentration, respectively (Figure 2(b)). As a result of comparing fluorescence intensity at the same concentration, the fluorescence intensity of alloy QDs was relatively stronger than that of commercial QDs. To confirm the anti-rabbit IgG antibody conjugation, we compared the QY and zeta potential of carboxyl group-functionalized QDs and antibody-conjugated QDs. After conjugating antibodies to QDs, QY was measured to determine how different the efficiency of commercial QDs and alloy QDs were. Carboxyl group-functionalized commercial QDs displayed a relatively low level of QY at 11.3%, with QY decreasing to 2.5% after antibody conjugation. On the other hand, carboxyl group-functionalized alloy QDs displayed a high QY of 84.5%, and this high QY was maintained even after antibody conjugation (83.0%) (Figures 3(a) and S3).

Before antibody conjugation, both QDs showed a higher negative charge due to the carboxyl group on the surface, whereas antibody-conjugated QDs showed less negative charge due to the antibody on the surface (Figure 3(b)). These findings indicated that the antibodies were successfully conjugated onto the surface of carboxyl group-functionalized QDs.

Additionally, cell viability experiments were conducted to confirm the suitability of biological experiments and particle stability of alloy QDs and common QDs (Figure S4). The results indicated the superiority of alloy QDs, which were used in further experiments.

3.2. QD-Based Sandwich Immunoassay Strategy

The anti-rabbit IgG antibody was used as a capture antibody, and it was used to the detection of rabbit IgG as target. The capture antibody was attached to the wells of high-binding immune plates through physical absorption. BSA was used to block the uncoated active sites to prevent nonspecific adsorption of the target in microplates. Different concentrations of the target were added for testing. Subsequently, detection antibody-conjugated QDs were bound with the target-capture antibody complex and formed the sandwich immunocomplex. As the decreased target concentration, the amount of capture antibody-conjugated QDs which bound as sandwich immunocomplex was also decreased, and as a result, the fluorescence intensity declined. Thus, it was feasible to determine the concentration of the target by monitoring the fluorescence intensity.

3.3. Optimization of Antibody-Conjugated QD Concentration

To get the optimized concentration of QDs (for sandwich immunoassay), we set the concentration of detection antibody- (anti-rabbit IgG) conjugated alloy QD variously between 0 and  ng mL-1. The experiment group proceeded with the capture antibody, target antibody, and detection antibody-conjugated QDs. Control group 1 used alloy QD-conjugated antibody and capture antibody, without target. Control group 2 used alloy QD-conjugated antibody and target, without capture antibody. The concentration of both capture antibody and target antibody was not changed during optimizing the concentration of detection antibody-conjugated QDs. As shown in Figure 4, we performed sandwich immunoassay and achieved strong fluorescence intensity at the experiment group, meanwhile weak fluorescence intensity at the control group. Weak fluorescence intensity of the control group is indicated for proving nonspecific binding. Consequentially, we confirmed that there was distinct fluorescence intensity at the experiment group and no significant nonspecific binding at control group 1 below the  ng mL-1 of detection antibody-conjugated QDs. So, the concentration of detection antibody-conjugated QDs was optimized as  ng mL-1, and QDs with optimized concentration were used by the same concentration ( ng mL-1) for the rabbit IgG detection experiment.

3.4. Performance of the Sandwich Immunoassay Using Alloy QDs for Rabbit IgG Detection

Under the optimized condition of detecting anti-rabbit IgG antibody-conjugated QDs ( ng mL-1 of detection antibody-conjugated QDs), we performed the sandwich immunoassay experiment for detecting of the rabbit IgG. To determine the limit of detection (LOD) of the rabbit IgG, the concentration of rabbit IgG was increased gradually from 0 (PBS buffer only) to  ng mL-1. The fluorescence intensity was gradually increased according to the increase of rabbit IgG concentration. Meanwhile, in the control group in which the capture antibody was absent, fluorescence intensity was almost the same at all concentrations of rabbit IgG. The maximum fluorescence intensity of both the experimental and control groups was compared to achieve the limit of detection; the LOD for the rabbit IgG was  ng mL-1 (3 S/N criteria) (Figures 5 and S5). Although these sensitivities were not exceptional [49], the results are important as they were the demonstration of the potential biological applications of new alloy QDs that QY was rarely dropped after surface modification. Alloy QDs could have diverse uses due to their remarkably bright fluorescence.

4. Conclusions

We fabricated the alloy QDs which have a high QY of 84.5%, and their ligand has a carboxyl group that can easily be used and versatile in surface modification. After surface modification, the alloy QDs have a QY of 83%. We compared the optical characteristics between commercial QDs and alloy QDs. The QY of commercial QDs decreased sharply after surface modification from 11.3% to 2.5%, whereas the QY of alloy QDs was stable even after surface modification. These results indicate that alloy QDs are more applicable than commercial QDs. Further experiments established the bioapplication of alloy QDs. In a sandwich immunoassay to detect rabbit IgG, the LOD was  ng mL-1. Combining these results, alloy QDs are more suitable for bioapplication than commercial QDs and have the potential for development.

Data Availability

The data used to support the findings of this study are available from the corresponding author upon request.

Conflicts of Interest

The authors declare that there is no conflict of interest regarding the publication of this paper.

Authors’ Contributions

Jaehyun An and Kim-Hung Huynh are co-first authors.

Acknowledgments

This research was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean Government (2019R1F1A106345412 and NRF-2017H1A2A1044051-Fostering Core Leaders of the Future Basic Science Program/Global Ph.D. Fellowship Program) and by the Korean Health Technology R&D Project, Ministry of Health & Welfare (HI17C1264).

Supplementary Materials

Figure S1 shows the DLS analysis result of alloy QDs. For the alloy QDs, the size of the particles in the water solvent was measured at 25.8 nm. Figure S2 shows the DLS analysis result of commercial QDs. For the commercial QDs, the size of the particles in the water solvent was measured at 762.3 nm. Figure S3 checked the digital image of each QDs. Prior to the conjugation of antibodies, the original alloy QDs had the strongest fluorescence intensity in the image. Figure S4 shows cell viability assay to assess cytotoxicity of alloy QDs. Human retinal pigment epithelial ARPE-19 cells were treated with various concentrations of alloy QDs or conventional QDs. Figure S5 shows LOD calculation. We used 3 S/N criteria to calculate LOD. (Supplementary Materials)